SCHEMBL30108077

SCHEMBL30108077

Nc1nc(-c2ccco2)cc(-n2nnc3cc(OCC4CCNCC4)ccc32)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.40
SLC6A4 P31645 4/20 0.40
KCNH2 Q12809 3/20 0.40
HTR3A P46098 2/20 0.40
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CCNA1 P78396 1/20 0.38
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
KHK P50053 2/20 0.36
SLC6A3 Q01959 3/20 0.36
PRKCZ Q05513 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HRH3 Q9Y5N1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108006 0.88 CCNA2 (0.36) CCNA2CDK2CCNA1KDM4EALDH1A1
SCHEMBL30107960 0.87 SLC6A2 (0.40) SLC6A2SLC6A4KCNH2HTR3ANOS3
SCHEMBL30108021 0.85 KDM4E (0.36) SLC6A2SLC6A4KCNH2HTR3ACCNA2
SCHEMBL30108002 0.82 ADORA2A (0.37) SLC6A2SLC6A4KCNH2HTR3ACCNA2
SCHEMBL30108022 0.81 SLC6A2 (0.37) SLC6A2SLC6A4KCNH2HTR3ACCNA2
SCHEMBL30107980 0.81 ROCK1 (0.45) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108046 0.81 KDM4E (0.39) CCNA2CDK2CCNA1KDM4EALDH1A1
SCHEMBL30107951 0.80 PTGS1 (0.46) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108028 0.79 KDM4E (0.43) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108012 0.75 TSHR (0.58) KDM4EALDH1A1GAAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed